Article

Challenges in 3D Bioprinting

Adam Feinberg, associate professor of Biomedical Engineering at Carnegie Mellon University, sat down with BioPharm International to discuss challenges in 3D bioprinting. 

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Continuous and Modular Manufacturing Innovations: Discussion with JP Bornholdt
August 30th 2025

Continuous and Modular Manufacturing Innovations: Discussion with JP Bornholdt (INTERPHEX 2023)

Trends in Bio/Pharma Facilities: Ken Gilmartin Gives His Perspecitve
August 30th 2025

Trends in Bio/Pharma Facilities: Ken Gilmartin Gives His Perspective (INTERPHEX 2023)

Bas Trietsch Discusses Successes so Far Using Organ on a Chip Technology for Bio/Pharmaceuticals
August 30th 2025

Bas Trietsch Discusses Successes so Far Using Organ on a Chip Technology for Bio/Pharmaceuticals (INTERPHEX 2023)

Organ on a Chip Technology: Discussion with Yaakov Nahmias
August 30th 2025

Organ on a Chip Technology: Discussion with Yaakov Nahmias (INTERPHEX 2023)

Organ on a Chip Data Integrity Discussion with Issac Bentwich
August 30th 2025

Organ on a Chip Data Integrity Discussion with Issac Bentwich (INTERPHEX 2023)

Talking Automation in Fill/Finish and Cell & Gene Therapies with James Rorke
August 30th 2025

Talking Automation in Fill/Finish and Cell & Gene Therapies with James Rorke (INTERPHEX 2023)

© 2025 MJH Life Sciences

All rights reserved.